R. A. Patchell, The management of brain metastases, Cancer Treat Rev, vol.29, pp.533-573, 2003.

R. A. Patchell, P. A. Tibbs, J. W. Walsh, R. J. Dempsey, Y. Maruyama et al., A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, vol.322, pp.494-500, 1990.

C. J. Vecht, H. Haaxma-reiche, E. M. Noordijk, G. W. Padberg, J. H. Voormolen et al., Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery, Ann Neurol, vol.33, pp.583-90, 1993.

M. Kocher, R. Soffietti, U. Abacioglu, S. Villà, F. Fauchon et al., Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study, J Clin Oncol, vol.29, pp.134-175, 2011.

R. A. Patchell, P. A. Tibbs, W. F. Regine, R. J. Dempsey, M. Mohiuddin et al., Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial, JAMA, vol.280, pp.1485-1494, 1998.

R. Soffietti, M. Kocher, U. M. Abacioglu, S. Villa, F. Fauchon et al., A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results, J Clin Oncol, vol.31, pp.65-72, 2013.

E. L. Chang, J. S. Wefel, K. R. Hess, P. K. Allen, F. F. Lang et al., Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial, Lancet Oncol, vol.10, pp.1037-1081, 2009.

P. D. Brown, K. V. Ballman, J. H. Cerhan, S. K. Anderson, X. W. Carrero et al., Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial, Lancet Oncol, vol.18, issue.17, pp.30441-30443, 2017.

C. Wang, S. R. Floyd, C. Chang, P. C. Warnke, C. C. Chio et al., Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen, J Neurooncol, vol.106, pp.601-611, 2012.

G. Minniti, V. Esposito, C. E. Scaringi, C. Lanzetta, G. Salvati et al., Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases, Int J Radiat Oncol Biol Phys, vol.86, pp.623-632, 2013.

F. Pessina, P. Navarria, L. Cozzi, A. M. Ascolese, G. Maggi et al., Outcome evaluation of oligometastatic patients treated with surgical resection followed by hypofractionated stereotactic radiosurgery (HSRS) on the tumor bed, for single, large brain metastases, PLoS ONE, vol.11, 2016.

A. Keller, M. Doré, H. Cebula, F. Thillays, F. Proust et al., Hypofractionated stereotactic radiation therapy to the resection bed for intracranial metastases, Int J Radiat Oncol Biol Phys, vol.99, pp.1179-89, 2017.

K. A. Ahmed, J. M. Freilich, Y. Abuodeh, N. Figura, N. Patel et al., Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases, J Neurooncol, vol.118, pp.179-86, 2014.

A. Al-omair, H. Soliman, W. Xu, A. Karotki, T. Mainprize et al., Hypofractionated stereotactic radiotherapy in five daily fractions for postoperative surgical cavities in brain metastases patients with and without prior whole brain radiation, Technol Cancer Res Treat, vol.12, pp.493-502, 2013.

P. Royston and M. Parmar, The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt, Stat Med, vol.30, pp.2409-2430, 2011.

A. Mahajan, S. Ahmed, M. F. Mcaleer, J. S. Weinberg, J. Li et al., Postoperative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial, Lancet Oncol, vol.18, issue.17, p.30414, 2017.

J. H. Gans, D. Raper, A. H. Shah, A. Bregy, D. Heros et al., The role of radiosurgery to the tumor bed after resection of brain metastases, Neurosurgery, vol.72, pp.317-342, 2013.

D. C. Ling, J. A. Vargo, R. E. Wegner, J. C. Flickinger, S. A. Burton et al., Postoperative stereotactic radiosurgery to the resection cavity for large brain metastases: clinical outcomes, predictors of intracranial failure, and implications for optimal patient selection, Neurosurgery, vol.76, pp.150-156, 2015.

A. J. Patel, D. Suki, M. A. Hatiboglu, H. Abouassi, W. Shi et al., Factors influencing the risk of local recurrence after resection of a single brain metastasis, J Neurosurg, vol.113, pp.181-190, 2010.

J. R. Robbins, S. Ryu, S. Kalkanis, C. Cogan, J. Rock et al., Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis, Neurosurgery, vol.71, pp.937-980, 2012.

B. M. Alexander, P. D. Brown, M. S. Ahluwalia, H. Aoyama, B. G. Baumert et al., Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group, Lancet Oncol, vol.19, pp.33-42, 2018.

E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, pp.228-275, 2009.

L. A. Jarvis, N. E. Simmons, M. Bellerive, K. Erkmen, C. J. Eskey et al., Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery, Int J Radiat Oncol Biol Phys, vol.84, pp.943-951, 2012.

H. Ogiwara, K. Kalakota, S. S. Rakhra, I. B. Helenowski, M. H. Marymont et al., Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases, J Neurooncol, vol.108, pp.141-147, 2012.

R. Prabhu, H. K. Shu, C. Hadjipanayis, A. Dhabaan, W. Hall et al., Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control, Int J Radiat Oncol Biol Phys, vol.83, pp.61-66, 2012.

B. Atalar, L. A. Modlin, C. Choi, J. R. Adler, I. C. Gibbs et al., Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases, Int J Radiat Oncol Biol Phys, vol.87, pp.713-721, 2013.

J. S. Barnholtz-sloan, C. Yu, A. E. Sloan, J. Vengoechea, M. Wang et al., A nomogram for individualized estimation of survival among patients with brain metastasis, Neuro Oncol, vol.14, pp.910-918, 2012.

H. Borghaei, L. Paz-ares, L. Horn, D. R. Spigel, M. Steins et al., Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N Engl J Med, vol.373, pp.1627-1666, 2015.

B. R. Eaton, M. J. Lariviere, L. Riviere, M. J. Kim, S. Prabhu et al., Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases, J Neurooncol, vol.123, pp.103-114, 2015.

E. Shaw, C. Scott, L. Souhami, R. Dinapoli, R. Kline et al., Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05, Int J Radiat Oncol Biol Phys, vol.47, pp.507-513, 2000.

G. Minniti, C. Scaringi, S. Paolini, G. Lanzetta, A. Romano et al., Single-fraction versus multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis, Int J Radiat Oncol Biol Phys, vol.95, pp.1142-1150, 2016.

H. Soliman, M. Ruschin, L. Angelov, P. D. Brown, V. Chiang et al., Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases, Int J Radiat Oncol Biol Phys, vol.100, pp.436-478, 2018.

E. M. Marchan, J. Peterson, T. T. Sio, K. L. Chaichana, A. C. Harrell et al., Postoperative cavity stereotactic radiosurgery for brain metastases, Front Oncol, vol.8, p.342, 2018.